Aceragen, Inc. to Delist from The Nasdaq Stock Market
04 Aug 2023 //
GLOBENEWSWIRE
Aceragen, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing
30 May 2023 //
GLOBENEWSWIRE
Aceragen Announces Recommendation of Data Monitoring Committee in Terra Study
06 Feb 2023 //
GLOBENEWSWIRE
Aeterna discontinues vaccine development; Idera rebrands as Aceragen
17 Jan 2023 //
ENDPTS